American Healthcare REIT (AHR) Insider Estes Buys 2,594 Shares

Scott Estes bought 2,594 shares of American Healthcare REIT, Inc. (AHR) on June 24, 2026. The shares were acquired at a market price around $51.69, reflecting a total investment value of approximately $134,314. This purchase follows a recent trend of insider buying within the company, suggesting confidence among its leaders.

Inside Scott Estes's Trade

Estes's recent purchase happened on the same day that other insiders, including Valerie Richardson and Mathieu Streiff, also bought 2,594 shares each. This indicates a collective interest from multiple insiders in American Healthcare REIT at a time of increased market activity.

Other Institutional Activity in American Healthcare REIT

Blackrock Inc. trimmed its holdings by 2,894,125 shares, ending with 25,845,948 shares worth about $1.37 billion. Vanguard Portfolio Management LLC grew its stake by 851,352 shares, bringing its total to 16,975,438 shares valued at approximately $898.3 million. Vanguard Capital Management LLC increased its holdings by 1,002,723 shares to a total of 9,201,599 shares, valued at about $486.9 million. State Street Corporation reduced its position by 499,216 shares to 9,046,025 shares worth around $478.7 million. Principal Financial Group, Inc. added 1,494,973 shares, resulting in a total of 8,917,875 shares valued at around $471.9 million.

American Healthcare REIT, Inc. Stock Down 2.5%

At $51.69, American Healthcare REIT's stock trades near its 52-week high of $58.70. The stock closed at $52.15 the previous day, showing some volatility in recent trading. Its performance is noteworthy as it approaches the next earnings date on November 5, 2026.

Recent Earnings

American Healthcare REIT reported revenue of approximately $2.5 billion, with a revenue growth of 24.7%. The company's earnings per share (EPS) stood at $0.68, and it achieved a net margin of about 4.83%. The next earnings report is anticipated on November 5, 2026.

Analysts Set New Price Targets

On October 13, 2026, UBS maintained a Buy rating for American Healthcare REIT with a price target of $62.00, down from $63.00. Barclays also maintained an Overweight rating with a new target of $60.00, reduced from $66.00. Raymond James initiated coverage with a Strong Buy rating and a target of $62.00. Scotiabank maintained a Sector Outperform rating with a target of $62.00, increased from $56.00. The consensus among analysts is a strong buy with a mean target price of $64.40 based on 15 opinions.

About American Healthcare REIT

American Healthcare REIT, Inc. is a self-managed real estate investment trust (REIT) based in Maryland. It owns and manages a diverse portfolio of healthcare real estate across the U.S., U.K., and the Isle of Man, focusing on senior housing and skilled nursing facilities. This recent insider activity may indicate confidence in its growing market position.

Bottom Line

Investors should watch how American Healthcare REIT performs as it approaches its earnings report in early November. This insider buying trend, along with strong analyst recommendations, could provide insight into the company's future performance. Remember, the recent Form 4 filings reflect trades completed by insiders and may not represent current holdings.